Molecular Fingerprint Screening in Trillion-Sized Chemical Spaces — Introduction to infiniSee 5 ‘Artemis’

webinar

Thu, 02 Mar 2023, 16:00 CET (Berlin)

Alexander Neumann, BioSolveIT

Molecular Fingerprint Screening in Trillion-Sized Chemical Spaces — Introduction to infiniSee 5 ‘Artemis’

Easy access to relevant chemistry around a lead compound is an integral part of fast follow up and ligand evolution. For this, molecular fingerprints represent long-standing industry standard tools to perform virtual screenings on data sets for compounds of interest akin to a query molecule. The novel SpaceLight algorithm extracts closely related compounds from ultra-large Chemical Spaces — using Tanimoto fingerprint similarity. Developed in collaboration with ZBH (University of Hamburg), SpaceLight has been further crafted and improved — debuting as the ‘Analog Hunter’ mode in the upcoming infiniSee 5 version.

In this BioSolveIT application webinar we will introduce you to infiniSee 5 ‘Artemis’, as well as the new Analog Hunter mode. Features and innovations will be discussed in detail to address different drug discovery scenarios.

Participants will receive a free 2 weeks license for infiniSee to explore trillions of possibilities for their drug discovery projects.

Current news

Entering The Trillion Era: AMBrosia Update
October 7, 2026 13:24 CEST
More chemistry. Trillions of possibilities. AMBrosia enters its third version with more than 2.4 trillion virtual product molecules. Developed in close collaboration with Ambinter (a brand of Greenpharma), the expanded Chemical Space combines 313,777 building blocks through 54 chemical reactions, implemented as 131 technical reactions, opening up a wealth of...
Read on
category
Events
DrugSpace 2026 Symposium - The Path to Digital Chemistry
October 6, 2026 11:28 CEST
Where Medicinal and Computational Chemistry Come Together We are delighted to invite drug hunters, compound enthusiasts, and molecule designers back to the virtual DrugSpace Symposium. The fifth edition takes place on December 9, 2026, under the theme “The Path to Digital Chemistry,” and turns the spotlight on where computational and...
Read on
category
Events
BioSolveIT at the Enamine Drug Discovery Conference 2026 in Riga
September 23, 2026 16:21 CEST
The Enamine Drug Discovery Conference in Riga (Latvia) comes to a close today. Our CEO Dr. Christian Lemmen and our SVP Application Science Dr. Marcus Gastreich spent the past four days, 20 to 23 September 2026, at the Radisson Blu Latvija Conference & Spa Hotel, and they return with much...
Read on